Fig. 3From: A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myelomaPharmacokinetic analyses. A Relationship between dose of and Cmax for orally administered NMP. B Relationship between dose and AUC. C Relationship between dose and concentration for a single patient with multiple dose increments. Cmax, maximum plasma concentration; AUC, area under curveBack to article page